These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Alpar HO; Somavarapu S; Atuah KN; Bramwell VW Adv Drug Deliv Rev; 2005 Jan; 57(3):411-30. PubMed ID: 15560949 [TBL] [Abstract][Full Text] [Related]
4. Exploiting receptor biology for oral vaccination with biodegradable particulates. Foster N; Hirst BH Adv Drug Deliv Rev; 2005 Jan; 57(3):431-50. PubMed ID: 15560950 [TBL] [Abstract][Full Text] [Related]
5. Development of oral vaccines for human use. Fooks AR Curr Opin Mol Ther; 2000 Feb; 2(1):80-6. PubMed ID: 11249655 [TBL] [Abstract][Full Text] [Related]
9. Design and delivery of non-parenteral vaccines. Nugent J; Po AL; Scott EM J Clin Pharm Ther; 1998 Aug; 23(4):257-85. PubMed ID: 9867311 [TBL] [Abstract][Full Text] [Related]
10. Induction of protective and mucosal immunity against diphtheria by a immune stimulating complex (ISCOMS) based vaccine. Aguila A; Donachie AM; Peyre M; McSharry CP; Sesardic D; Mowat AM Vaccine; 2006 Jun; 24(24):5201-10. PubMed ID: 16650917 [TBL] [Abstract][Full Text] [Related]
11. Liposomes as delivery systems for nasal vaccination: strategies and outcomes. Heurtault B; Frisch B; Pons F Expert Opin Drug Deliv; 2010 Jul; 7(7):829-44. PubMed ID: 20459361 [TBL] [Abstract][Full Text] [Related]
13. [Oral vaccination and vaccine-entrapped microparticle delivery system]. Li FQ; Fei YB; Su H; Hu JH Yao Xue Xue Bao; 2007 Mar; 42(3):245-51. PubMed ID: 17520821 [TBL] [Abstract][Full Text] [Related]
14. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria. van Roosmalen ML; Kanninga R; El Khattabi M; Neef J; Audouy S; Bosma T; Kuipers A; Post E; Steen A; Kok J; Buist G; Kuipers OP; Robillard G; Leenhouts K Methods; 2006 Feb; 38(2):144-9. PubMed ID: 16414272 [TBL] [Abstract][Full Text] [Related]
15. Gut-associated lymphoid tissues for the development of oral vaccines. Kunisawa J; Kurashima Y; Kiyono H Adv Drug Deliv Rev; 2012 May; 64(6):523-30. PubMed ID: 21827802 [TBL] [Abstract][Full Text] [Related]
16. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. Felnerova D; Viret JF; Glück R; Moser C Curr Opin Biotechnol; 2004 Dec; 15(6):518-29. PubMed ID: 15560978 [TBL] [Abstract][Full Text] [Related]
17. Mucosal delivery of vaccine antigens and its advantages in pediatrics. De Magistris MT Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335 [TBL] [Abstract][Full Text] [Related]
20. AIDS vaccine: Intranasal immunization using inactivated HIV-1-capturing core-corona type polymeric nanospheres. Akagi T; Ueno M; Hiraishi K; Baba M; Akashi M J Control Release; 2005 Dec; 109(1-3):49-61. PubMed ID: 16256237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]